The significance of deep frequencies and ways of stabilising patients during treatment

Hans Brügemann, Gräfelfing, Germany

It is no secret that a series of important rhythms having a considerable influence on our regulatory systems – and hence on our health – lie in the low-frequency range. The most important frequency is probably the Schumann wave. What is this Schumann wave all about? Here I must go into a slightly lengthier explanation.

Since the work of the German physicist O. W. Schumann (1888-1978), we have known that magnetic AC fields which have an influence on humans – so-called Schumann waves – are present in nature. Thus, humans live in an electric and magnetic AC field between the Earth’s surface and the ionosphere.

This AC field is stimulated by solar activity, storms, and the transition from day to night.

When, for example, a bolt of lightning strikes somewhere on the Earth, it is not just a local occurrence. The lightning generates impulses which travel around the whole planet, because they are reflected in this cavity resonator by the ionosphere and the Earth’s surface. Thus, there are powerful standing waves which remain stable over a long time.

The following experiment was conducted: Students had to stay in totally shielded underground rooms for a fairly long period of time. They were therefore shielded from Schumann waves. The consequence: Their body rhythms were ‘derailed’, and a significant negative impact on their wellbeing was observed.

In space capsules, there are built-in generators simulating Schumann waves; otherwise, humans would not be able to remain for any length of time in outer space.

Incidentally, the micromagnetic field pulse characteristic of the DMI section of the BICOM 2000 is modelled on the natural pulses of Schumann waves.

All life on Earth needs Schumann waves. The physicist Prof. König, a disciple of Prof. Schumann’s, accurately calculated the frequencies of Schumann waves. The lowest frequency is 7.8 Hz.

Significantly, the hippocampal wave, which exerts a decisive influence on brain function, shares the same frequency, i.e. 7.8 Hz.

Back in the early 1990’s, the physicist Dr Wolfgang Ludwig reported that the US military in Alaska was operating an enormous HAARP antenna system with extremely high power levels. This system uses the properties of a cavity resonator in order to broadcast signals in this frequency range as well. This is a secret project of the American military. There is much speculation on the aim and purpose of the project. Whatever it may be, it may be assumed that the system also generates disturbance frequencies in this range which are capable of adversely influencing the human organism.

Other known brain waves also lie in the ultra-long wave range:

These are frequencies radiated by the brain, i.e. from the control centre of the body, which naturally have a decisive influence on all bodily processes.

Interestingly, frequencies for auricular diagnosis according to Nogier also lie in this Extremely Low Frequency range. The lowest frequency is 1.14 Hz. Additional frequencies are 2.28, 4.56, 6.84 and 9.12 Hz.

Russian researchers also use the frequencies under 10 Hz for special diagnosis systems.

We may therefore assume that the lowest frequencies play an important role in regulating our organisms.

Many years ago, I told our electronic engineers that we needed a bandpass14 in this Extremely Low Frequency (ELF) range.

The engineers’ response was always that this was not technically possible. But I stuck to my guns, and lo and behold, after a long time in development, modern electronic components have finally made possible the creation of a bandpass in this Extremely Low Frequency range.

This electronic master stroke nevertheless required brand new hardware and software. The 1 –25 Hz bandpass requires its very own electronics module that cannot be ‘grafted onto’ the previous bandpass electronics in the BICOM® device.

This special electronic circuit spans the 1 – 25 Hz range. The bandpass requires at least 2 minutes for a 1 – 25 Hz sweep, since it builds up slowly in accordance with the law, i.e. requires a particular amount of time to ‘move into position’ in the desired frequency range.

The BICOM® prototype with a bandpass in the Extremely Low Frequency range was tested in practices over a fairly long period of time. During its use, a very good therapeutic effect was observed. Among other things, for example, it was noticed that when this frequency range was used, eliminations onto the footplate applicators were markedly stronger than was normally the case with the previous equipment.

We had now finally succeeded in accessing the Extremely Low Frequency range for bioresonance treatment, yet this required completely new hardware and software. The obvious next step, therefore, was to think about a new, enhanced BICOM® device.

We’ve now managed to turn these thoughts into reality!

am pleased to be able to present to you the new BICOM® device: the BICOM BICOM optima®.

A third therapy unit for stabilisation

The title of my presentation also mentions the possibility of stabilising patients during therapy. For this, a further therapy module with therapy type A and with a second input channel are incorporated in the BICOM BICOM optima®. This module enables us to apply the information from stabilising substances, e.g. ampoules from the 5-element set, organ ampoules or supporting medicines, etc. concurrently with treatment with the body’s own frequency patterns, or during the elimination of specific stresses. In this way, the stressed organ systems can be stabilised and supported in a time-saving manner, and any initial worsening can be minimised.

Attached to this 2nd input is a honeycomb in which the appropriate ampoules may be inserted. In addition, however, a glass cup may be placed in the honeycomb if other substances for stabilisation are to be oscillated. We call this new therapy module

‘Channel 2’. It too has been put through its paces in therapy practices, and today we shall find out what was observed when Channel 2 was included.

The BICOM BICOM optima® contains five therapy units performing mutually complementary tasks:

• The basic module: treatment with frequency patterns produced naturally in the body and in substances

• The magnetic field module: Dynamic Multi-Impulse (DMI) therapy for energy regulation

• The stabilisation module (Channel 2): for stabilising and supporting stressed organ systems

• The substance-complex module: stored frequency patterns of therapeutics to support treatment

• The potentiation module: for treatment with similar potencies

New options for the amplification sweep

First of all, a basic observation. We deploy the amplification sweep in order to record all of the patient’s interference zones, without having to test amplifications individually.

Dr. Hennecke, Mrs. Maquinay and Mrs. Karz have now suggested further variants for the amplification sweep (see Fig. 3). Dr. Hennecke and Mrs. Maquinay discovered that a falling amplification sweep during the treatment of viruses, bacteria and parasites leads to the expectation of better results than a rising amplification sweep. We have therefore included this option in the new BICOM BICOM optima®.

Moreover, Mrs. Karz has suggested making available a symmetrical amplification sweep (see Fig. 4 c). In this function, the amplification rises up to the set height, then falls to the lowest amplification, rises again and falls again. This variant of the amplification sweep also increases the therapeutic options, about which we’re now about to hear more.

This symmetrical amplification sweep can also be applied to the reciprocal (reverse) amplification sweep for H and Di.

Further details on the new BICOM BICOM optima® device

Larger display with graphical interface
The larger display considerably increases ease of operation; users are guided through the entire menu and instructed on the texts and the numbers to be pressed.

The launch window (Fig. 5) has 9 main menu buttons from where you can quickly get to the desired area.

The graphic display also serves to illustrate the applicator layout for the input and the applicator layout for the output for each program, as can be seen in the two figures (Fig. 6 and Fig. 7). Over 1000 programs are stored.

Programs in the Extremely Low Frequency range
One hundred and thirty five new programs have been added to the Extremely Low Frequency range between 1 und 25 Hz. These were developed by Mrs. Karz, for which she deserves our heartfelt thanks. The numbers for all these programs have been allocated in the 3000 range.

Tried-and-tested program combinations as series programs

About one-and-a-half years ago we published two booklets containing triedand-tested program combinations for human, veterinary and dental practices. These consisted of 2 to 6 programs run in series.

We call these program combinations ‘program series’. Two hundred and twenty nine program series are stored and ready to use. The applicator layout is illustrated for these program series as well. All you need do, therefore, is activate the program series and launch it after adding the contents to the cup and arranging the applicators appropriately. All programs stored in the program series run automatically. Should the applicators need to be rearranged, the series stops and the new applicator arrangement can be called up, displayed in both text and graphics.

Channel 2 therapy unit (for stabilisation)
To operate Channel 2 there is a dedicated launch key with the wording ‘Start Channel 2’. A window then appears on the screen from where the amplification and treatment time can also be modified if necessary. Therapy type A cannot be modified, however.

Over 400 substance complexes stored

Over 400 stored substance complexes can be retrieved and activated using menu button 6. They can be selected according to alphabetical order or category.

These substance complexes often contain a nosode, as well as further information on constructive substances specially related to this nosode which promotes elimination and stabilises and supports the organs. Many of the substance complexes can simply be selected according to indications. With other substance complexes it is necessary to test whether the patient needs them. These substance complexes are intended as a ‘hidden reserve’, in cases where the desired success is not achieved with a patient by using the familiar therapy options. Among other things, these substance complexes contain e.g. the category of ‘goodies’. These encompass inter alia constructive substance complexes for elderly males and constructive substance complexes for elderly females. Combined with a constructive DMI treatment and a basic therapy with H oscillations and extremely low frequencies, these provide a veritable fountain of youth.

Brief notes on further details

• The RS 232 interface has been replaced by 2 USB ports.

• A slot is now available for an SD card (chip) to allow updates.

• The knob of the earlier version has been replaced by a cross-over switch allowing 5 functions to be performed.

• The new equipment feet also serve as a tidy storage place for the banana plugs of the cables not currently being used.

• The test socket for the cable test is no longer on the rear of the device, but is now easily accessible at the front. The cables remain plugged in at the back of the device as for during treatment. The other end of the cable is simply plugged into the test socket at the front. This means that the cable test is much easier to perform.

• The standard range and the conductance ranges for the various basic therapies are highlighted in colour on the illuminated EAP dial.

• Instead of the carry handle at the side, there is a pull-out carry handle on the underside of the device.

• There is now a resilient low-pressure applicator for EAV testing. It is a significant help in testing, since it makes the plateau that displays the proper test value substantially easier to recognise. This aids in the achievement of reproducible test results. The resilient low-pressure applicator represents a considerable help, particularly for novices in electro-acupuncture diagnosis according to Voll (EAV).

Prospects

It is to be expected that the new BICOM BICOM optima® device will considerably increase treatment efficacy, reduce treatment time and number of visits, especially for chronic patients, and offer an even greater range of testing and treatment options. In an era of increasing lifestyle diseases, this is particularly useful.

The advantages of the improved ease of operation will soon be appreciated in everyday practice too, as will the enhanced opportunities for delegating therapy. I am convinced that you will appreciate these latest developments and enhancements.